Medicine & Life Sciences
Multiple Myeloma
100%
Short Stature, Auditory Canal Atresia, Mandibular Hypoplasia, Skeletal Abnormalities
48%
Thalidomide
47%
Fibroblast Growth Factor Receptors
21%
komaroviquinone
19%
Genes
17%
phthalimide
13%
Stomach Neoplasms
12%
Intercellular Signaling Peptides and Proteins
12%
Bone Marrow
12%
Apoptosis
11%
Therapeutics
11%
Angiogenesis Inducing Agents
11%
Lenalidomide
9%
Fibroblast Growth Factor 2
9%
Pharmaceutical Preparations
9%
Silicon Dioxide
9%
Cell Line
9%
Extracellular Vesicles
8%
Neoplasms
8%
Temperature
8%
Fibroblast Growth Factor 7
8%
Biological Products
8%
Complementary DNA
8%
Bone Marrow Cells
7%
Stem Cell Transplantation
7%
nucleophosmin
7%
Messenger RNA
7%
anilinoquinazoline
7%
Bortezomib
7%
Neutropenia
6%
Chromosome Aberrations
6%
Static Electricity
6%
Proteins
6%
Stem Cells
6%
HLA-A24 Antigen
6%
condensin complexes
6%
Hematologic Neoplasms
5%
Cell Separation
5%
Leukemia, Megakaryoblastic, Acute
5%
Receptor Protein-Tyrosine Kinases
5%
glutathione S-transferase M1
5%
glutathione S-transferase T1
5%
T-Lymphocytes
5%
Thrombopoietin Receptors
5%
Hydrophobic and Hydrophilic Interactions
5%
Lymphoma
5%
Troglitazone
5%
Growth
5%
Intestinal Pseudo-Obstruction
5%
Chemical Compounds
Komaroviquinone
16%
Drug
15%
Cytogenetics
14%
Phthalimide
9%
Haematological
9%
Lenalidomide
9%
Growth Factor
8%
Anti Myeloma
8%
Antitumor
7%
Intraperitoneal
7%
Column Like Crystal
6%
Troglitazone
6%
Occurrence in Nature
6%
Block Copolymer
6%
Gefitinib
6%
Insulin-Like Growth Factor I
5%
Pharmacokinetics
5%
Angiogenic
5%